Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial

This publication has 25 references indexed in Scilit:

• Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial
  Lung Cancer, 1994
• Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group
  European Journal Of Cancer, 1993
• Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomized phase II study : Postmus PE, Splinter TAW, Palmen FMLHG, Carney DN, Festen J, Burghouts JThW et al. Department of Pulmonary Diseases, University Hospital, Oostersingel 59, 9713 EZ Groningen. Eur J Cancer 1992;28:96–100
  Lung Cancer, 1992
• Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study
  European Journal Of Cancer, 1992
• Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer
  Annals of Internal Medicine, 1987
• Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung
  Cancer Treatment Reviews, 1984
• Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease
  New England Journal of Medicine, 1982
• Alkylating agents in bronchogenic carcinoma
  The American Journal of Medicine, 1969
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958